Deferasirox Tablet, For Suspension
Product Images NDC 0480-7012

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 0480-7012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Deferasirox Tabs Fos A207124 1)

Chemical structure of Deferasirox, showing its molecular framework including aromatic rings and hydroxyl groups.*

FDA Label Image

Figure 1 (Deferasirox Tabs Fos A207124 2)

A bar chart depicting the change in liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L) at different Deferasirox doses (mg/kg/day). The x-axis shows doses of 5, 10, 20, and 30 mg/kg/day, with sample sizes indicated. Liver iron content changes are shown with white bars, serum ferritin changes with black bars. The y-axes measure changes in liver iron content on the left and serum ferritin on the right.*

FDA Label Image

Label, 125 mg, 30s (Deferasirox Tabs Fos A207124 3)

Label for Deferasirox Tablets for Oral Suspension, 125 mg per tablet, by Teva Pharmaceuticals, Inc. The label includes dosage instructions emphasizing tablets must be dispersed in water or juice before ingestion. It indicates the package contains 30 tablets for oral use and is marked Rx only.*

FDA Label Image

Label, 250 mg, 30s (Deferasirox Tabs Fos A207124 4)

Deferasirox Tablets for Oral Suspension 250 mg per tablet packaging label. The label indicates the product is from Teva Pharmaceuticals, Inc., includes 30 tablets for oral suspension, and provides instructions that tablets must be dispersed in water, orange, or apple juice prior to ingestion. Prescription only.*

FDA Label Image

Label, 500 mg, 30s (Deferasirox Tabs Fos A207124 5)

Deferasirox Tablets for Oral Suspension, 500 mg per tablet, packaged by Teva Pharmaceuticals, Inc. The label indicates a 30-tablet count and includes instructions to dispense an accompanying Medication Guide. Additional storage and handling warnings are present, including directions to not chew or swallow tablets whole and to disperse tablets in water, orange, or apple juice before ingestion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.